Cindy Stern
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cindy Stern has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
- Danielle Pollock
Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Adelaide University, Adelaide, SA, Australia
13 shared publications - Zachary Munn
Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Adelaide University, Adelaide, SA, Australia
12 shared publications - Timothy Hugh Barker
Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Adelaide University, Adelaide, SA, Australia
11 shared publications - Edoardo Aromataris
JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
9 shared publications - Ashley Whitehorn
JBI, School of Public Health, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
6 shared publications - Camille Schubert
Adelaide Health Technology Assessment (AHTA), School of Public Health, University of Adelaide, Adelaide, SA, Australia
5 shared publications
Latest Publications
- 20 October 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (11) , 2385-2397
Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol
Objective: This scoping review will identify methodological guidance relevant to systematic reviews (SRs), clinical practice guidelines (CPGs), and health technology assessments (HTAs) for rare diseases, and examine methodological challenges associated with their development. Introduction: Rare diseases affect approximately 400 million people worldwide. However, individual rarity limits health care provider knowledge and awareness and, subsequently, management of rare diseases is hindered by diagnostic delays, limited treatment options, and high treatment costs. Heterogeneous populations and sparse, low-quality evidence also impede research quality and render traditional evidence evaluation methods ill-suited to rare diseases. Consequently, existing methodological frameworks guiding evidence-based development of SRs, CPGs, and HTAs may not appropriately consider contextual nuances of rare diseases. Eligibility criteria: This scoping review will consider both peer-reviewed and gray literature relevant to methodological guidance for SRs, CPGs, and HTAs. Eligible sources will focus on rare diseases collectively, or specific conditions that meet the criteria of a rare disease, and address at least 1 aspect of methodology used to develop SRs, CPGs, or HTAs relevant to rare disease contexts. Methods: The 3-step search strategy began with an exploratory PubMed search to refine terms, which will be followed by comprehensive searches in MEDLINE, Embase, Scopus, and the Cochrane Library. Gray literature will be searched via Google Scholar, Orphanet, the World Health Organization Institutional Repository for Information Sharing, the International Network of Agencies for Health Technology Assessment, and the National Institute for Health and Care Excellence. Identified sources will be independently screened, selected, and extracted by multiple reviewers. Data will be analyzed using descriptive statistics and qualitative content analysis, then presented in summary tables and summarized descriptively. Review registration: OSF https://osf.io/mrfev
- 20 October 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (11) , 2385-2397
Identifying methodological guidance used for systematic reviews, clinical practice guidelines, and health technology assessment for rare diseases: a scoping review protocol
Objective: This scoping review will identify methodological guidance relevant to systematic reviews (SRs), clinical practice guidelines (CPGs), and health technology assessments (HTAs) for rare diseases, and examine methodological challenges associated with their development. Introduction: Rare diseases affect approximately 400 million people worldwide. However, individual rarity limits health care provider knowledge and awareness and, subsequently, management of rare diseases is hindered by diagnostic delays, limited treatment options, and high treatment costs. Heterogeneous populations and sparse, low-quality evidence also impede research quality and render traditional evidence evaluation methods ill-suited to rare diseases. Consequently, existing methodological frameworks guiding evidence-based development of SRs, CPGs, and HTAs may not appropriately consider contextual nuances of rare diseases. Eligibility criteria: This scoping review will consider both peer-reviewed and gray literature relevant to methodological guidance for SRs, CPGs, and HTAs. Eligible sources will focus on rare diseases collectively, or specific conditions that meet the criteria of a rare disease, and address at least 1 aspect of methodology used to develop SRs, CPGs, or HTAs relevant to rare disease contexts. Methods: The 3-step search strategy began with an exploratory PubMed search to refine terms, which will be followed by comprehensive searches in MEDLINE, Embase, Scopus, and the Cochrane Library. Gray literature will be searched via Google Scholar, Orphanet, the World Health Organization Institutional Repository for Information Sharing, the International Network of Agencies for Health Technology Assessment, and the National Institute for Health and Care Excellence. Identified sources will be independently screened, selected, and extracted by multiple reviewers. Data will be analyzed using descriptive statistics and qualitative content analysis, then presented in summary tables and summarized descriptively. Review registration: OSF https://osf.io/mrfev
- Open Access
- 8 September 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (4) , e70089
Response to: Comment on ‘The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis’
- 8 September 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (4) , e70089
Open AccessResponse to: Comment on ‘The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis’
- Open Access
- 15 July 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (3)
The Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis
Aim: To synthesise quantitative evidence on the values and preferences of people living with Motor Neurone Disease (MND), caregivers, and genetic carriers regarding health‐related outcomes to inform the Australian MND Guideline. Methods: A systematic review was conducted following Cochrane and GRADE guidance, informed by an a priori protocol. Major electronic databases (including MEDLINE, Embase, CENTRAL) and trial registries were searched to identify studies that met the eligibility criteria. Risk of bias of the studies that met the eligibility criteria was assessed using the Risk of Bias in Studies of Values and Utilities (ROBVALU) tool. Data on health state utility values were synthesised using meta‐analysis where appropriate, while other quantitative data deemed inappropriate for meta‐analysis were synthesised narratively. The certainty of the evidence for each outcome was assessed using the GRADE approach. Results: Twenty‐four studies ( n = 10,397) were included. Overall health‐related quality of life (hrQoL) utility values for adults with MND varied significantly based on the regional preference set utilised (mean EQ‐5D utility ranging from 0.57 in UK cohort (high certainty in the evidence) to 0.72 in Chinese cohorts (low certainty in the evidence). Utility values declined consistently with increasing disease severity across multiple staging systems, such as King's and MiToS. Narrative synthesis identified clear preferences across physical, psychosocial, and healthcare domains regarding both current and hypothetical treatment strategies. Conclusion: This review provides a comprehensive synthesis of the values and preferences of the broad MND community. This review has been conducted following rigorous best‐practice methodology, to directly inform the selection and prioritisation of outcomes for the development of the Australian MND Guideline, ensuring the guideline adheres to a patient‐centred approach. Standardisation of preference elicitation methods from the MND community, and the development of a core outcome set for future MND research are key future priorities.
- 15 July 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (3)
Open AccessThe Values and Preferences of People Living With Motor Neurone Disease (MND): A Systematic Review and Meta‐Analysis
Aim: To synthesise quantitative evidence on the values and preferences of people living with Motor Neurone Disease (MND), caregivers, and genetic carriers regarding health‐related outcomes to inform the Australian MND Guideline. Methods: A systematic review was conducted following Cochrane and GRADE guidance, informed by an a priori protocol. Major electronic databases (including MEDLINE, Embase, CENTRAL) and trial registries were searched to identify studies that met the eligibility criteria. Risk of bias of the studies that met the eligibility criteria was assessed using the Risk of Bias in Studies of Values and Utilities (ROBVALU) tool. Data on health state utility values were synthesised using meta‐analysis where appropriate, while other quantitative data deemed inappropriate for meta‐analysis were synthesised narratively. The certainty of the evidence for each outcome was assessed using the GRADE approach. Results: Twenty‐four studies ( n = 10,397) were included. Overall health‐related quality of life (hrQoL) utility values for adults with MND varied significantly based on the regional preference set utilised (mean EQ‐5D utility ranging from 0.57 in UK cohort (high certainty in the evidence) to 0.72 in Chinese cohorts (low certainty in the evidence). Utility values declined consistently with increasing disease severity across multiple staging systems, such as King's and MiToS. Narrative synthesis identified clear preferences across physical, psychosocial, and healthcare domains regarding both current and hypothetical treatment strategies. Conclusion: This review provides a comprehensive synthesis of the values and preferences of the broad MND community. This review has been conducted following rigorous best‐practice methodology, to directly inform the selection and prioritisation of outcomes for the development of the Australian MND Guideline, ensuring the guideline adheres to a patient‐centred approach. Standardisation of preference elicitation methods from the MND community, and the development of a core outcome set for future MND research are key future priorities.
- 26 June 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (10) , 2201-2210
Reliability of lung ultrasound in adult patients in emergency and intensive care settings: a systematic review protocol
Objective: This review aims to assess the intrarater and interrater reliability of lung ultrasound (LUS) in adult patients in emergency and intensive care settings, and to understand the associated influencing factors. Introduction: LUS is an increasingly important tool for diagnosis and monitoring of diseases of the respiratory system, especially in emergency and intensive care settings. LUS findings, however, are largely dependent on operator technique and expertise to identify and interpret images. Thus, concerns remain about its reliability across different examiners and clinical settings. A comprehensive review of reliability, specifically intrarater and interrater, is needed to ensure the accuracy and reproducibility of LUS findings in clinical practice. Eligibility criteria: The review will include studies of LUS examinations on adult patients (>18 years) receiving care in emergency or intensive care settings for the investigation of any signs, symptoms, or conditions suggestive of alteration of the respiratory system. Studies published from the 1990s to the present will be considered for inclusion, without restriction on language or methodological quality. Methods: The review will follow Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) for systematic reviews. The search will be conducted in MEDLINE (Ovid), Embase (Ovid), Web of Science, CINAHL (EBSCOhost), Scopus, and gray literature sources. Two reviewers will independently assess studies against predefined criteria and the COSMIN Risk of Bias tool. Intrarater and interrater reliability of relevant LUS findings will be extracted and synthesized, with meta-analyses and subgroup analysis, where relevant. Review registration: PROSPERO CRD420251081274
- 26 June 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (10) , 2201-2210
Reliability of lung ultrasound in adult patients in emergency and intensive care settings: a systematic review protocol
Objective: This review aims to assess the intrarater and interrater reliability of lung ultrasound (LUS) in adult patients in emergency and intensive care settings, and to understand the associated influencing factors. Introduction: LUS is an increasingly important tool for diagnosis and monitoring of diseases of the respiratory system, especially in emergency and intensive care settings. LUS findings, however, are largely dependent on operator technique and expertise to identify and interpret images. Thus, concerns remain about its reliability across different examiners and clinical settings. A comprehensive review of reliability, specifically intrarater and interrater, is needed to ensure the accuracy and reproducibility of LUS findings in clinical practice. Eligibility criteria: The review will include studies of LUS examinations on adult patients (>18 years) receiving care in emergency or intensive care settings for the investigation of any signs, symptoms, or conditions suggestive of alteration of the respiratory system. Studies published from the 1990s to the present will be considered for inclusion, without restriction on language or methodological quality. Methods: The review will follow Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) for systematic reviews. The search will be conducted in MEDLINE (Ovid), Embase (Ovid), Web of Science, CINAHL (EBSCOhost), Scopus, and gray literature sources. Two reviewers will independently assess studies against predefined criteria and the COSMIN Risk of Bias tool. Intrarater and interrater reliability of relevant LUS findings will be extracted and synthesized, with meta-analyses and subgroup analysis, where relevant. Review registration: PROSPERO CRD420251081274
- 6 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 459-513
Evidence synthesis methodology for questions relating to barriers and enablers in health care: a scoping review
Objective: The objective of this scoping review was to map the range of methodologies and methods used to undertake evidence synthesis aimed at determining barriers and/or enablers in health care, and to inform further research relevant to synthesis methodology in this area. Introduction: Questions related to identifying and exploring barriers and/or enablers within health care are becoming increasingly popular. Currently, there are multiple approaches to synthesizing this evidence, and it is unclear whether a more consistent approach is warranted. Eligibility criteria: Evidence synthesis on barriers and/or enablers (facilitators) that included interest-holders at different levels of the health system were considered. Evidence synthesis projects had to include primary research studies and were published from 2010 to 2021. Literature reviews, narrative reviews, and umbrella reviews were excluded, as were reviews published in languages other than English. Methods: This scoping review followed JBI methodology and was based on a published a priori protocol and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A 3-step search strategy using a combination of key terms and index headings was undertaken in October 2021 via the following databases/resources: PubMed, Embase, CINAHL (EBSCOhost), PsycINFO (Ovid), Cochrane Database of Systematic Reviews, JBI Evidence Synthesis , and EPPI-Centre Systematic Reviews. An extensive piloting process for screening and selection, and data extraction was undertaken due to the large number of reviewers involved. All records were screened independently by 2 reviewers, and any disagreements were resolved through either a third reviewer or discussion with a panel of reviewers. Extraction was undertaken using a customized form, and data were analyzed using descriptive statistics. Data are presented via tables, figures, a word cloud, and an infographic, supplemented with a narrative synthesis. Results: Following completion of the search, 24,823 records were screened and 774 reviews were included in the scoping review. Systematic reviews were the most commonly used methodology (68%) to synthesize barrier and/or enabler questions. Reviews often included diverse types of evidence and involved an assessment of methodological quality (70%). Findings related to barriers and/or enablers were usually grouped and organized into categories, often by thematic methods (33%) or a narrative approach (20%). Incongruencies related to nomenclature, missing information, and methods used were evident across the large dataset. Conclusions: A variety of methodological approaches are being followed to undertake reviews focused on barriers and/or enablers in health care. The current state of the literature indicates that most authors answer these questions via the conduct of a systematic review and include diverse types of evidence. Further work is needed to determine whether authors are unclear when deciding on methodology and whether guidance is required.
- 6 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 459-513
Evidence synthesis methodology for questions relating to barriers and enablers in health care: a scoping review
Objective: The objective of this scoping review was to map the range of methodologies and methods used to undertake evidence synthesis aimed at determining barriers and/or enablers in health care, and to inform further research relevant to synthesis methodology in this area. Introduction: Questions related to identifying and exploring barriers and/or enablers within health care are becoming increasingly popular. Currently, there are multiple approaches to synthesizing this evidence, and it is unclear whether a more consistent approach is warranted. Eligibility criteria: Evidence synthesis on barriers and/or enablers (facilitators) that included interest-holders at different levels of the health system were considered. Evidence synthesis projects had to include primary research studies and were published from 2010 to 2021. Literature reviews, narrative reviews, and umbrella reviews were excluded, as were reviews published in languages other than English. Methods: This scoping review followed JBI methodology and was based on a published a priori protocol and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A 3-step search strategy using a combination of key terms and index headings was undertaken in October 2021 via the following databases/resources: PubMed, Embase, CINAHL (EBSCOhost), PsycINFO (Ovid), Cochrane Database of Systematic Reviews, JBI Evidence Synthesis , and EPPI-Centre Systematic Reviews. An extensive piloting process for screening and selection, and data extraction was undertaken due to the large number of reviewers involved. All records were screened independently by 2 reviewers, and any disagreements were resolved through either a third reviewer or discussion with a panel of reviewers. Extraction was undertaken using a customized form, and data were analyzed using descriptive statistics. Data are presented via tables, figures, a word cloud, and an infographic, supplemented with a narrative synthesis. Results: Following completion of the search, 24,823 records were screened and 774 reviews were included in the scoping review. Systematic reviews were the most commonly used methodology (68%) to synthesize barrier and/or enabler questions. Reviews often included diverse types of evidence and involved an assessment of methodological quality (70%). Findings related to barriers and/or enablers were usually grouped and organized into categories, often by thematic methods (33%) or a narrative approach (20%). Incongruencies related to nomenclature, missing information, and methods used were evident across the large dataset. Conclusions: A variety of methodological approaches are being followed to undertake reviews focused on barriers and/or enablers in health care. The current state of the literature indicates that most authors answer these questions via the conduct of a systematic review and include diverse types of evidence. Further work is needed to determine whether authors are unclear when deciding on methodology and whether guidance is required.
- 6 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 420-437
Bias-adjusted meta-analysis using the quality effects model: a Stata tutorial
Meta-analysis is a widely employed method for the synthesis of effect sizes across diverse studies; however, traditional meta-analytic models do not address potential bias due to systematic error. In response, bias-adjusted models of meta-analysis have emerged. One of these is the quality effects (QE) model that was introduced as an approach specifically designed to adjust pooled estimates using information from methodological quality assessments. In this paper, we guide researchers step-by-step through the bias-adjustment process using the QE model in Stata (metan package), which provides functions for performing a QE meta-analysis.
- 6 March 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 420-437
Bias-adjusted meta-analysis using the quality effects model: a Stata tutorial
Meta-analysis is a widely employed method for the synthesis of effect sizes across diverse studies; however, traditional meta-analytic models do not address potential bias due to systematic error. In response, bias-adjusted models of meta-analysis have emerged. One of these is the quality effects (QE) model that was introduced as an approach specifically designed to adjust pooled estimates using information from methodological quality assessments. In this paper, we guide researchers step-by-step through the bias-adjustment process using the QE model in Stata (metan package), which provides functions for performing a QE meta-analysis.
- Open Access
- 4 February 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (2)
Mapping Evidence on Care Interventions for People Living With Motor Neurone Disease: A Protocol for a Living Evidence and Gap Map
Objective: To map the available evidence informing the care and management of people living with motor neurone disease (MND), including evidence pertaining to carers, asymptomatic genetic carriers, family, friends and healthcare professionals caring for people with MND. Introduction: MND is a devasting neurodegenerative disease that has no cure and eventually leads to paralysis, progressive speech difficulties and respiratory failure. There are a plethora of interventions to support people living with MND, however, information regarding these interventions is often not organised in a manner that best supports the MND community. An evidence and gap map will provide a visual presentation that highlights the existing evidence that is available to support specific interventions, and indicate where there is no evidence. This will help inform future guideline and research efforts. Inclusion Criteria: Studies if they describe care interventions for people living with MND, carers, asymptomatic genetic carriers, family, friends and healthcare professionals caring for people with MND. Peer‐reviewed randomised controlled trials, and nonrandomised studies of interventions, systematic reviews and qualitative studies describing the experience of an intervention will be included. Methods: An evidence and gap map will be conducted according to Campbell guidance and JBI guidance for scoping reviews. A comprehensive search of academic databases and clinical trial registries will be performed to identify eligible studies. An evidence inclusion framework has been developed with members of the MND community. Data screening and extraction will be independently performed by two reviewers. The evidence and gap map will be presented using EPPI Reviewer. Review Registration: This protocol has been uploaded to the Australian Motor Neurone Disease (MND) Guideline Open Science Framework page ( https://osf.io/c2ezm/ ).
- 4 February 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (2)
Open AccessMapping Evidence on Care Interventions for People Living With Motor Neurone Disease: A Protocol for a Living Evidence and Gap Map
Objective: To map the available evidence informing the care and management of people living with motor neurone disease (MND), including evidence pertaining to carers, asymptomatic genetic carriers, family, friends and healthcare professionals caring for people with MND. Introduction: MND is a devasting neurodegenerative disease that has no cure and eventually leads to paralysis, progressive speech difficulties and respiratory failure. There are a plethora of interventions to support people living with MND, however, information regarding these interventions is often not organised in a manner that best supports the MND community. An evidence and gap map will provide a visual presentation that highlights the existing evidence that is available to support specific interventions, and indicate where there is no evidence. This will help inform future guideline and research efforts. Inclusion Criteria: Studies if they describe care interventions for people living with MND, carers, asymptomatic genetic carriers, family, friends and healthcare professionals caring for people with MND. Peer‐reviewed randomised controlled trials, and nonrandomised studies of interventions, systematic reviews and qualitative studies describing the experience of an intervention will be included. Methods: An evidence and gap map will be conducted according to Campbell guidance and JBI guidance for scoping reviews. A comprehensive search of academic databases and clinical trial registries will be performed to identify eligible studies. An evidence inclusion framework has been developed with members of the MND community. Data screening and extraction will be independently performed by two reviewers. The evidence and gap map will be presented using EPPI Reviewer. Review Registration: This protocol has been uploaded to the Australian Motor Neurone Disease (MND) Guideline Open Science Framework page ( https://osf.io/c2ezm/ ).
- 28 January 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (4) , 791-797
Medical inpatient experiences and perceptions of discharge education provided by health care professionals: a qualitative systematic review protocol
Objective: The objective of this review is to synthesize the experiences and perceptions of adult medical inpatients regarding discharge education provided by health care professionals during their hospital stay, when patients are discharged from hospital to home. Introduction: Discharge education is an essential part of patient care, helping individuals prepare to manage their health once they leave the hospital. Many patients face significant challenges in adjusting to life outside the hospital following discharge, and these challenges can provide valuable insights into their needs in terms of the discharge process. Eligibility criteria: This review will consider qualitative studies exploring the perceptions and experiences of adult medical inpatients who received discharge education from health care professionals and were discharged from hospital to home. Studies published in English and Portuguese, regardless of publication date or geographic origin, will be eligible. Methods: This review will follow the JBI methodology for systematic reviews of qualitative evidence. A comprehensive literature search will be conducted across the following databases: PubMed, CINAHL (EBSCOhost), Scopus, Embase (Ovid), Emcare (Ovid), LILACS (BVS), and ERIC (EBSCOhost). ProQuest Dissertations and Theses Global will be searched for gray literature. Two reviewers will independently screen and appraise studies and then extract data. For data synthesis, a meta-aggregative approach will be used. The ConQual approach will be employed for assessing the confidence in the evidence. The results of the search and the study inclusion process will be reported in full in the final systematic review and presented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. Review registration: PROSPERO CRD420250641761
- 28 January 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (4) , 791-797
Medical inpatient experiences and perceptions of discharge education provided by health care professionals: a qualitative systematic review protocol
Objective: The objective of this review is to synthesize the experiences and perceptions of adult medical inpatients regarding discharge education provided by health care professionals during their hospital stay, when patients are discharged from hospital to home. Introduction: Discharge education is an essential part of patient care, helping individuals prepare to manage their health once they leave the hospital. Many patients face significant challenges in adjusting to life outside the hospital following discharge, and these challenges can provide valuable insights into their needs in terms of the discharge process. Eligibility criteria: This review will consider qualitative studies exploring the perceptions and experiences of adult medical inpatients who received discharge education from health care professionals and were discharged from hospital to home. Studies published in English and Portuguese, regardless of publication date or geographic origin, will be eligible. Methods: This review will follow the JBI methodology for systematic reviews of qualitative evidence. A comprehensive literature search will be conducted across the following databases: PubMed, CINAHL (EBSCOhost), Scopus, Embase (Ovid), Emcare (Ovid), LILACS (BVS), and ERIC (EBSCOhost). ProQuest Dissertations and Theses Global will be searched for gray literature. Two reviewers will independently screen and appraise studies and then extract data. For data synthesis, a meta-aggregative approach will be used. The ConQual approach will be employed for assessing the confidence in the evidence. The results of the search and the study inclusion process will be reported in full in the final systematic review and presented in a Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. Review registration: PROSPERO CRD420250641761
- 19 December 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 514-526
User experience and adoption of automation and AI for evidence synthesis: a scoping review protocol
Objective: The objective of this scoping review will be to chart the available evidence on user experience and adoption of automation and artificial intelligence (AI) technologies for evidence synthesis. Introduction: Evidence syntheses are crucial for informing health care practice and policy; however, they are constrained by the ever-increasing volume of research and labor-intensive methods. With reviews often taking over a year to complete, automation and AI offer promising solutions by streamlining evidence synthesis workflows. However, while these technologies may offer significant time savings, their adoption depends on usability, trustworthiness, and workflow integration—elements that are currently poorly understood. Eligibility criteria: This review will include primary research articles, all types of reviews, expert opinions, and gray literature that discuss user experience/adoption of automation and AI technologies for evidence synthesis across all disciplines. Methods: Following JBI scoping review methodology, the search strategy will identify published and unpublished evidence sources using a 3-step process. An initial exploratory search of PubMed was conducted to identify relevant keywords and terms. This will be followed by searches of PubMed, Web of Science Core Collection, Scopus, ProQuest Central, and ACM Digital Library databases, as well as online gray literature sources to identify eligible studies. A date limit of October 2015 will be applied to the searches, with no language limitations. Three reviewers will independently screen, select, and extract data from relevant evidence sources. Data extraction and analysis will be charted and mapped through the lenses of 4 distinct frameworks: Unified Theory of Acceptance and Use of Technology (UTAUT), Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM), Human–AI Interaction (HAI), and user experience (UX) principles. Review registration: OSF https://osf.io/ayqjc/overview
- 19 December 2025
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (3) , 514-526
User experience and adoption of automation and AI for evidence synthesis: a scoping review protocol
Objective: The objective of this scoping review will be to chart the available evidence on user experience and adoption of automation and artificial intelligence (AI) technologies for evidence synthesis. Introduction: Evidence syntheses are crucial for informing health care practice and policy; however, they are constrained by the ever-increasing volume of research and labor-intensive methods. With reviews often taking over a year to complete, automation and AI offer promising solutions by streamlining evidence synthesis workflows. However, while these technologies may offer significant time savings, their adoption depends on usability, trustworthiness, and workflow integration—elements that are currently poorly understood. Eligibility criteria: This review will include primary research articles, all types of reviews, expert opinions, and gray literature that discuss user experience/adoption of automation and AI technologies for evidence synthesis across all disciplines. Methods: Following JBI scoping review methodology, the search strategy will identify published and unpublished evidence sources using a 3-step process. An initial exploratory search of PubMed was conducted to identify relevant keywords and terms. This will be followed by searches of PubMed, Web of Science Core Collection, Scopus, ProQuest Central, and ACM Digital Library databases, as well as online gray literature sources to identify eligible studies. A date limit of October 2015 will be applied to the searches, with no language limitations. Three reviewers will independently screen, select, and extract data from relevant evidence sources. Data extraction and analysis will be charted and mapped through the lenses of 4 distinct frameworks: Unified Theory of Acceptance and Use of Technology (UTAUT), Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM), Human–AI Interaction (HAI), and user experience (UX) principles. Review registration: OSF https://osf.io/ayqjc/overview